Related Experiment Video
Updated: Mar 31, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
21.3K
Peri-operative radiation exposure: Are overweight patients at increased risks?
S Dalgleish1, A Hince2, D F Finlayson3
1Raigmore Hospital, Trauma and Orthopaedics, Old Perth Road, Inverness, IV2 3UJ, United Kingdom.
Injury
|October 24, 2015
Summary
Overweight patients undergoing hip fracture surgery experience higher intra-operative radiation exposure, specifically in dose area product, irrespective of screening time. This highlights a need for radiation safety awareness for surgical staff.
Area of Science:
- Orthopedic Surgery
- Radiology
- Patient Safety
Background:
- Intra-operative radiation exposure is a concern in orthopedic procedures.
- Body Mass Index (BMI) may influence radiation dose during surgery.
Purpose of the Study:
- To investigate the correlation between patient BMI and intra-operative radiation exposure during femoral neck fracture fixation.
Main Methods:
- Retrospective review of 81 patients undergoing sliding hip screw fixation.
- Data collected included BMI, screening time, Dose Area Product (DAP), ASA grade, surgeon seniority, and fracture complexity.
Main Results:
- A significant positive correlation was found between Dose Area Product (DAP) and BMI.
- No significant relationship was observed between screening time and BMI.
- Overweight patients showed increased simulated stochastic risks and higher radiation doses.
Conclusions:
- Increased BMI is associated with higher radiation doses (DAP) during femoral neck fracture surgery.
- Surgeons, theatre staff, and radiographers must be aware of and mitigate increased radiation risks for overweight patients.
- While individual patient risk may be low, staff exposure is a significant concern.
Related Concept Videos
01:13Radiological Investigation III: Pulmonary Angiogram and PET Scan
625
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
625
01:21Drug Dosing: Obese Patients
341
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
341
01:30Radiological Investigation I: X-ray and CT
1.6K
Radiological investigations, including X-rays and computed tomography (CT) scans, are critical for diagnosing and evaluating various medical conditions. These imaging techniques provide valuable insights into the body's internal structures, aiding in the detection of abnormalities, assessment of disease progression, and development of treatment strategies. This article delves into two primary radiological investigations, chest X-rays and CT scans, outlining their purpose, procedures, and...
1.6K
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
381
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
381
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
283
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
283